Vital Chemtech Ltd IPO
Open Demat Account
Vital Chemtech Ltd IPO Details
Details
Total Shares Offered | Offer to Public | Retail Max (Shares) | Pre Issue Promoters Holding | Exchange | Issue size |
---|---|---|---|---|---|
₹ 64 L | TBA | ₹ 21.3 L | TBA | NSE | ₹ 64.64 Cr |
IPO Open Date | Close Date | Lot Size | Min Investment | Issue Type | Listing Date |
31 Oct, 22 | 03 Nov, 22 | 1200 | ₹ 1,14,000 | Book Building - SME | 14 Nov, 22 |
Vital Chemtech Ltd IPO Dates
Details
Sector | Type |
---|---|
Sector | Chemicals |
Sub Sector | NA |
Issue Type | Book Building - SME |
Subscription Status
*Values are in Lakhs
Investor Type | Subscription Times | Shares Offered* | Shares Bid* |
---|---|---|---|
QIB | 0x | 3037600 | 0 |
NII | 0x | 912000 | 0 |
Retail | 0x | 2130000 | 0 |
Employee | 0x | 0 | 0 |
Total | 0x | 6399600 | 0 |
Subscription Status
Investor Type
QIB
NII
Retail
Employee
Total
*Values are in Lakhs
Vital Chemtech Ltd Financial Status
Income Statement
Balance Sheet
Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
---|---|---|---|
Revenue from operations | 133.90 | 98.27 | 116.74 |
EBITDA | 10.91 | 9.27 | 16.12 |
PAT | 4.63 | 4.02 | 8.05 |
Total Assets | 60.77 | 58.41 | 90.22 |
Share Capital | 23.95 | 23.95 | 23.95 |
Total Borrowings | 11.23 | 11.47 | 15.60 |
Operating Activities (Net Cash) | 6.71 | 6.20 | 10.37 |
Investing Activities (Net Cash) | 19.44 | 33.94 | 15.26 |
Financing Activities (Net Cash) | 11.23 | 11.47 | 15.60 |
Net Cashflow | 0.51 | 0.40 | 29.26 |
Particulars (in Rs. Crores)
Revenue from operations
EBITDA
PAT
Total Assets
Share Capital
Total Borrowings
Operating Activities (Net Cash)
Investing Activities (Net Cash)
Financing Activities (Net Cash)
Net Cashflow
About Vital Chemtech Ltd
Following more than two years of pandemic, spillovers from the Russian Federation's invasion of Ukraine are set to sharply hasten the deceleration of global economic activity, which is now expected to slow to 2.9 percent in 2022. The war in Ukraine is leading to high commodity prices, adding to supply disruptions, increasing food insecurity and poverty, exacerbating inflation, contributing to tighter financial conditions, magnifying financial vulnerability, and heightening policy uncertainty. Growth in emerging market and developing economies (EMDEs) this year has been downgraded to 3.4 percent, as negative spillovers from the invasion of Ukraine more than offset any near-term boost to some commodity exporters from higher energy prices. Despite the negative shock to global activity in 2022, there is essentially no rebound projected next year: global growth is forecast to edge up only slightly to a still-subdued 3 percent in 2023, as many headwinds-in particular, high commodity prices and continued monetary tightening-are expected to persist. Moreover, the outlook is subject to various downside risks, including intensifying geopolitical tensions, growing stagflationary headwinds, rising financial instability, continuing supply strains, and worsening food insecurity. These risks underscore the importance of a forceful policy response. The global community needs to ramp up efforts to mitigate human- itarian crises caused by the war in Ukraine and conflict elsewhere and alleviate food insecurity, as well as expand vaccine access to ensure a durable end of the pandemic. Meanwhile, EMDE policy makers need to refrain from implementing export restrictions or price controls, which could end up magnifying the increase in commodity prices. With rising inflation, tightening financial con- ditions, and elevated debt levels sharply limiting policy space, spending can be reprioritized toward targeted relief for vulnerable households. Over the long run, policies will be required to reverse the damage inflicted by the dual shocks of the pandemic and the war on growth prospects, Including preventing fragmentation in trade networks, improving education, and raising labor force participation. Russia's invasion of Ukraine is affecting EMDE regions to different degrees via impacts on global trade and output, commodity prices, inflation, and interest rates. The adverse spillovers from the war will be most severe for Europe and Central Asia, where output is forecast to sharply contract this year. Output growth is projected to slow this year in all other regions except the Middle East and North Africa, where the benefits of higher energy prices for energy exporters are expected to outweigh those prices' negative impacts for other economies in the region. Risks for all EMDE regions are tilted to the downside and include intensifying geo- political tensions, rising inflation and food shortages, financial stress and rising borrowing costs, renewed outbreaks of COVID-19, and disruptions from disasters.
The Company is engaged in the business of manufacturing of Phosphorus Derivatives. The Company is manufacturer and supplier of Phosphorus base chemicals with highest quality practice and complient with Highest Environmental, Health, and Safety (EHS) in chemical industry.
Peer Comparison:
- Neogen Chemicals Ltd
Vital Chemtech Ltd IPO Key Points
Strengths
- Experienced Promoters and Management Team
- Prime Location of its Manufacturing Facility
- Diversified product portfolio
- Long-standing relationships with a diversified customer base
- Consistent financial performance
Risk
- The company do not own the premises in which its registered office is located and the same is on lease arrangement. Any termination of such lease/license and/or non-renewal thereof and attachment by lender could adversely affect its operations.
- Some of the raw materials that the company use as well as its finished products are hazardous, corrosive and flammable and require expert handling and storage, as applicable. Any accidents may result in loss of life or property and disrupt its operations which may have an adverse effect on the company results of operation, cash flows and financial condition.
- The Company, Promoters, Directors and group Companies are involved in certain litigations including tax related litigations, which if determined against them/us, can affect financial conditions of the company.
Strategy
- Continue improving financial performance through focus on operational and functional efficiencies
- Increase in Installed Capacity on year on year basis.
- Leveraging its market skills, relationship and leadership position in Phosphorus Derivatives
- Increase wallet share with existing customers and continued focus to expand customer base
- Experienced Promoters and Management Team
- Prime Location of its Manufacturing Facility
- Diversified product portfolio
- Long-standing relationships with a diversified customer base
- Consistent financial performance
How To Apply for Vital Chemtech Ltd IPO Online?
Step 1:
Log in to the BlinkX stock market app and click ‘IPO’ in the Xplore section.
Step 2:
From the list of open IPOs, select the IPO you want to invest.
Step 3:
Go through the IPO details like lot size, price band, about the company, etc.
Step 4:
Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.
Step 5:
Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.